Showing 1 - 20 results of 132 for search '(( date reported decrease ) OR ( ai ((large decrease) OR (marked decrease)) ))', query time: 0.39s Refine Results
  1. 1

    Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx by Rasita Vinay (21006911)

    Published 2025
    “…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Self-Report Questionnaires. by Michael R. Lawrence (21369854)

    Published 2025
    “…Biomarker analyses suggest possible prolonged inflammatory processes in long COVID patients compared to fully recovered patients. Results of decreased neuroplastic functioning give credence to patients’ reports of post-COVID changes in brain function.…”
  12. 12

    Characteristics of AEs reports. by Qian Guo (107009)

    Published 2025
    “…</p><p>Methods</p><p>This research implemented a disproportionality analysis to assess the safety of toripalimab by reviewing all adverse event reports from the FAERS database dating back to 2004, wherein toripalimab was recognized as the main suspected medication. …”
  13. 13

    A novel RNN architecture to improve the precision of ship trajectory predictions by Martha Dais Ferreira (18704596)

    Published 2025
    “…This type of monitoring often relies on the use of navigation systems such as the Automatic Identification System (AIS). AIS data has been used to support the defense teams when identifying equipment defects, locating suspicious activity, ensuring ship collision avoidance, and detecting hazardous events. …”
  14. 14
  15. 15

    Data Sheet 1_Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and... by Tao Wang (12008)

    Published 2025
    “…Introduction<p>To date, only two drugs, pirfenidone and nintedanib, are approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF). …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20